<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>To explore whether antibodies against beta2-<z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (beta2GPI) complexed to 7-ketocholesteryl-9-carboxynonanoate (oxLig-1) and to oxidised <z:chebi fb="2" ids="39026">low-density lipoproteins</z:chebi> (oxLDL) relate to paraoxonase activity (PONa) and/or intima media thickness (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e>) of carotid arteries in <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (PAPS) </plain></SENT>
<SENT sid="1" pm="."><plain>As many as 29 thrombotic patients with PAPS, 10 subjects with idiopathic <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) without <z:mp ids='MP_0005048'>thrombosis</z:mp>, 17 thrombotic patients with inherited <z:hpo ids='HP_0100724'>thrombophilia</z:hpo> and 23 healthy controls were investigated </plain></SENT>
<SENT sid="2" pm="."><plain>The following were measured in <z:hpo ids='HP_0000001'>all</z:hpo> participants: beta2GPI-oxLDL complexes, IgG anti-beta2GPI-oxLig-1, IgG anti-beta2GPI-oxLDL antibodies (ELISA), PONa, (para-<z:chebi fb="0" ids="39362">nitrophenol</z:chebi> method), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of common carotid (CC) artery, carotid bifurcation (B), internal carotid (IC) by high resolution sonography </plain></SENT>
<SENT sid="3" pm="."><plain>Beta2GPI-oxLDL complex was highest in the control group (p &lt; 0.01), whereas, IgG anti-beta2GPI-oxLig1 and IgG anti-beta2GPI-oxLDL were highest in PAPS (p &lt; 0.0001) </plain></SENT>
<SENT sid="4" pm="."><plain>In healthy controls, beta2GPI-oxLDL complexes positively correlated to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of the IC (p = 0.007) and negatively to PONa after correction for age (p &lt; 0.03) </plain></SENT>
<SENT sid="5" pm="."><plain>PONa inversely correlated with age (p = 0.008) </plain></SENT>
<SENT sid="6" pm="."><plain>In PAPS, IgG anti-beta2GPI-oxLig-1 independently predicted PONa (p = 0.02) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of B (p = 0.003), CC, (p = 0.03) and of IC (p = 0.04) </plain></SENT>
<SENT sid="7" pm="."><plain>In PAPS, PONa inversely correlated to the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">IMT</z:e> of B, CC and IC (p = 0.01, 0.02 and 0.003, respectively) </plain></SENT>
<SENT sid="8" pm="."><plain>IgG anti-beta2GPI-oxLig-1 may be involved in PAPS related atherogenesis via decreased PON activity </plain></SENT>
</text></document>